CVE-2023-42435: Dexma Dexgate

High severity, CVSS 8.8. EPSS: 0.2% chance of exploitation in the next 30 days.

The affected product is vulnerable to a cross-site request forgery vulnerability, which may allow an attacker to perform actions with the permissions of a victim user.

Affected products

• Dexma Dexgate: version 20130114 only

Published 2023-10-19. Last modified 2026-06-17.